Too often, investors are spooked by a market drop and make the mistake of selling weak shares.

Earnings season has started quite strong and the recent developments in Europe should keep bears in check.

Equity valuations, while still attractive, are no longer the bargain they were back in August and September.

Whether precious metals rise or fall, investors could perhaps profit from the gold/platinum ratio returning to something a little closer to normal.

The healthcare giant is one of our largest individual company positions, because it has the best combination of factors we can find for the future we envision.

While long-term I am bullish about the company's prospects, short-term I am less optimistic and shall be looking to exit my position.

Why I'm using any weakness in this stock as an opportunity to accumulate new shares.

China could play rescuer, but what's in it for them?

After the dust settles, these two stocks may look interesting.